{"id":9014,"date":"2020-10-12T12:33:05","date_gmt":"2020-10-12T10:33:05","guid":{"rendered":"https:\/\/www.precidiab.org\/?p=9014"},"modified":"2022-08-18T12:44:09","modified_gmt":"2022-08-18T10:44:09","slug":"type-2-diabetes-a-new-step-towards-personalized-medicine","status":"publish","type":"post","link":"https:\/\/www.precidiab.org\/en\/news\/type-2-diabetes-a-new-step-towards-personalized-medicine\/","title":{"rendered":"Type 2 diabetes: a new step towards personalized medicine"},"content":{"rendered":"\t\t<div data-elementor-type=\"wp-post\" data-elementor-id=\"9014\" class=\"elementor elementor-9014\" data-elementor-post-type=\"post\">\n\t\t\t\t\t\t<main class=\"elementor-section elementor-top-section elementor-element elementor-element-40c37ccd elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"40c37ccd\" data-element_type=\"section\" data-e-type=\"section\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<article class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-6520137f\" data-id=\"6520137f\" data-element_type=\"column\" data-e-type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-text-editor elementor-element elementor-element-d854b43 elementor-widget elementor-widget-text-editor\" data-id=\"d854b43\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p><strong>Patients with type 2 diabetes may carry a DNA mutation whose identification would allow more precise management. The results of a LabEx E.G.I.D. (European Genomic Institute for Diabetes), published in Nature Metabolism, pave the way for clinical trials for personalized treatments.<\/strong><\/p>\n<p>About 5 million people in France have type 2 diabetes. This number is expected to increase, along with the figures for obesity, sedentary lifestyle and the aging of the population. However, current multi-drug therapies do not prevent the occurrence of degenerative complications.<\/p>\n<p>Inheritance plays a major role (around 70%) in the development of type 2 diabetes, interacting with environmental risk factors. While \u201cactionable\u201d genes (allowing the personalization of treatments) have been identified for monogenic diabetes (less than 1% of cases), the hypothesis of genetic mutations allowing the optimization of treatments for the 99% of patients apparently suffering. of non-monogenic type 2 diabetes still remained unanswered.<\/p>\n<p>In order to test this hypothesis, the Lille and London team of Dr Am\u00e9lie Bonnefond (University of Lille \/ CNRS \/ Inserm \/ CHU de Lille \/ Institut Pasteur de Lille \/ Imperial College London) and Professor Philippe Froguel (University of Lille \/ CNRS \/ Inserm \/ Lille University Hospital \/ Institut Pasteur de Lille \/ Imperial College London), analyzed the genomes of a panel of 74,629 individuals from French, English and American studies. These results revealed that more than 2% of patients with type 2 diabetes in mature adults, ie 100,000 people in France, carried mutations in actionable genes linked to monogenic diabetes. More specifically, the gene encoding glucokinase (the first gene for monogenic diabetes identified in 1992 by the Lille team), but also the HNF4A, KCNJ11, HNF1B and ABCC8 genes.<\/p>\n<p>It has already been proven that familial diabetes linked to glucokinase only very rarely gets complicated. However, these patients undergo heavy and restrictive treatments, such as insulin injections which could be stopped or reduced. For carriers of the other actionable genes, inexpensive and existing non-insulin treatments would be more effective. The results of this new Lille study will ultimately allow a finer mesh in the diagnosis and prevent the patients concerned from treatments that are not very effective because they do not target the cause of diabetes.<\/p>\n<p>As personalized diabetes medicine is the main objective of the Lille National Center for Precision Medicine PreciDIAB, these promising results will make it possible to launch intervention research projects for these patients carrying mutations in the actionable genes of monogenic diabetes.<\/p>\n<p><span style=\"text-decoration: underline;\"><em>Publication reference:<\/em><\/span><br \/><em>Pathogenic variants in actionable MODY genes associated with type 2 diabetes.<\/em><br \/><em>Am\u00e9lie Bonnefond, Mathilde Boissel, Alexandre Bolze, Emmanuelle Durand, B\u00e9n\u00e9dicte Toussaint, Emmanuel Vaillant, Stefan Gaget, Franck De Graeve, Aur\u00e9lie Dechaume, Fr\u00e9d\u00e9ric Allegaert, David Le Guilcher, Lo\u00efc Yengo, V\u00e9ronique Dhennin, Jean-Michel Borys, James T. Lu , Elizabeth T. Cirulli, Gai Elhanan, Ronan Roussel, Beverley Balkau, Michel Marre, Sylvia Franc, Guillaume Charpentier, Martine Vaxillaire, Micka\u00ebl Canouil, Nicole L. Washington, Joseph J. Grzymski, Philippe Froguel.<\/em><\/p>\n<p><a class=\"external-link-new-window\" title=\"Opens external link in new window\" href=\"https:\/\/www.nature.com\/articles\/s42255-020-00294-3\" target=\"_blank\" rel=\"nofollow noopener\">Check out the review in Nature Metabolism<\/a><\/p>\n<p><a class=\"external-link-new-window\" title=\"Opens external link in new window\" href=\"https:\/\/www.univ-lille.fr\/fileadmin\/user_upload\/presse\/presse_2020\/VF08102020_CP_ULille_EGID_Diab%C3%A8teType2.pdf\" target=\"_blank\" rel=\"nofollow noopener\">Download the CP<\/a><\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/article>\n\t\t\t\t\t<\/div>\n\t\t<\/main>\n\t\t\t\t<\/div>\n\t\t","protected":false},"excerpt":{"rendered":"<p>Patients with type 2 diabetes may carry a DNA mutation whose identification would allow more precise management. The results of a LabEx E.G.I.D. (European Genomic Institute for Diabetes), published in Nature Metabolism, pave the way for clinical trials for personalized treatments. About 5 million people in France have type 2 diabetes. This number is expected [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":3078,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"gallery","meta":{"_acf_changed":false,"_monsterinsights_skip_tracking":false,"site-sidebar-layout":"default","site-content-layout":"default","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","ast-disable-related-posts":"","theme-transparent-header-meta":"default","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"footnotes":""},"categories":[1,35],"tags":[],"class_list":["post-9014","post","type-post","status-publish","format-gallery","has-post-thumbnail","hentry","category-actualite","category-communique-de-presse","post_format-post-format-gallery"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.2 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Type 2 diabetes: a new step towards personalized medicine | Precidiab<\/title>\n<meta name=\"description\" content=\"Patients with type 2 diabetes may carry a DNA mutation whose identification would allow more precise management.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.precidiab.org\/en\/news\/type-2-diabetes-a-new-step-towards-personalized-medicine\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Type 2 diabetes: a new step towards personalized medicine | Precidiab\" \/>\n<meta property=\"og:description\" content=\"Patients with type 2 diabetes may carry a DNA mutation whose identification would allow more precise management.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.precidiab.org\/en\/news\/type-2-diabetes-a-new-step-towards-personalized-medicine\/\" \/>\n<meta property=\"og:site_name\" content=\"Precidiab\" \/>\n<meta property=\"article:published_time\" content=\"2020-10-12T10:33:05+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2022-08-18T10:44:09+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.precidiab.org\/wp-content\/uploads\/2020\/10\/Nature-Metabolism-Logo.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"660\" \/>\n\t<meta property=\"og:image:height\" content=\"330\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"btourbier\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"btourbier\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.precidiab.org\\\/en\\\/news\\\/type-2-diabetes-a-new-step-towards-personalized-medicine\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.precidiab.org\\\/en\\\/news\\\/type-2-diabetes-a-new-step-towards-personalized-medicine\\\/\"},\"author\":{\"name\":\"btourbier\",\"@id\":\"https:\\\/\\\/www.precidiab.org\\\/en\\\/#\\\/schema\\\/person\\\/d6ca115531c8ad59974f11050ababc79\"},\"headline\":\"Type 2 diabetes: a new step towards personalized medicine\",\"datePublished\":\"2020-10-12T10:33:05+00:00\",\"dateModified\":\"2022-08-18T10:44:09+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.precidiab.org\\\/en\\\/news\\\/type-2-diabetes-a-new-step-towards-personalized-medicine\\\/\"},\"wordCount\":488,\"publisher\":{\"@id\":\"https:\\\/\\\/www.precidiab.org\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/www.precidiab.org\\\/en\\\/news\\\/type-2-diabetes-a-new-step-towards-personalized-medicine\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.precidiab.org\\\/wp-content\\\/uploads\\\/2020\\\/10\\\/Nature-Metabolism-Logo.jpg\",\"articleSection\":[\"Actualit\u00e9s\",\"Communiqu\u00e9s de presse\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.precidiab.org\\\/en\\\/news\\\/type-2-diabetes-a-new-step-towards-personalized-medicine\\\/\",\"url\":\"https:\\\/\\\/www.precidiab.org\\\/en\\\/news\\\/type-2-diabetes-a-new-step-towards-personalized-medicine\\\/\",\"name\":\"Type 2 diabetes: a new step towards personalized medicine | Precidiab\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.precidiab.org\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.precidiab.org\\\/en\\\/news\\\/type-2-diabetes-a-new-step-towards-personalized-medicine\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.precidiab.org\\\/en\\\/news\\\/type-2-diabetes-a-new-step-towards-personalized-medicine\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.precidiab.org\\\/wp-content\\\/uploads\\\/2020\\\/10\\\/Nature-Metabolism-Logo.jpg\",\"datePublished\":\"2020-10-12T10:33:05+00:00\",\"dateModified\":\"2022-08-18T10:44:09+00:00\",\"description\":\"Patients with type 2 diabetes may carry a DNA mutation whose identification would allow more precise management.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.precidiab.org\\\/en\\\/news\\\/type-2-diabetes-a-new-step-towards-personalized-medicine\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.precidiab.org\\\/en\\\/news\\\/type-2-diabetes-a-new-step-towards-personalized-medicine\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.precidiab.org\\\/en\\\/news\\\/type-2-diabetes-a-new-step-towards-personalized-medicine\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.precidiab.org\\\/wp-content\\\/uploads\\\/2020\\\/10\\\/Nature-Metabolism-Logo.jpg\",\"contentUrl\":\"https:\\\/\\\/www.precidiab.org\\\/wp-content\\\/uploads\\\/2020\\\/10\\\/Nature-Metabolism-Logo.jpg\",\"width\":660,\"height\":330},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.precidiab.org\\\/en\\\/news\\\/type-2-diabetes-a-new-step-towards-personalized-medicine\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.precidiab.org\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Type 2 diabetes: a new step towards personalized medicine\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.precidiab.org\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/www.precidiab.org\\\/en\\\/\",\"name\":\"Precidiab\",\"description\":\"Centre National de M\u00e9decine de Pr\u00e9cision des Diab\u00e8tes\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.precidiab.org\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.precidiab.org\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.precidiab.org\\\/en\\\/#organization\",\"name\":\"Precidiab\",\"url\":\"https:\\\/\\\/www.precidiab.org\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.precidiab.org\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.precidiab.org\\\/wp-content\\\/uploads\\\/2022\\\/07\\\/Logo-PRECIDIAB.png\",\"contentUrl\":\"https:\\\/\\\/www.precidiab.org\\\/wp-content\\\/uploads\\\/2022\\\/07\\\/Logo-PRECIDIAB.png\",\"width\":600,\"height\":257,\"caption\":\"Precidiab\"},\"image\":{\"@id\":\"https:\\\/\\\/www.precidiab.org\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.precidiab.org\\\/en\\\/#\\\/schema\\\/person\\\/d6ca115531c8ad59974f11050ababc79\",\"name\":\"btourbier\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/ede517e541c034054feafdd8a7a03fd3293fc75d1b87991c98533026c9921d33?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/ede517e541c034054feafdd8a7a03fd3293fc75d1b87991c98533026c9921d33?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/ede517e541c034054feafdd8a7a03fd3293fc75d1b87991c98533026c9921d33?s=96&d=mm&r=g\",\"caption\":\"btourbier\"},\"sameAs\":[\"https:\\\/\\\/precidiab.tw-es1.ovh\"],\"url\":\"https:\\\/\\\/www.precidiab.org\\\/en\\\/author\\\/btourbier\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Type 2 diabetes: a new step towards personalized medicine | Precidiab","description":"Patients with type 2 diabetes may carry a DNA mutation whose identification would allow more precise management.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.precidiab.org\/en\/news\/type-2-diabetes-a-new-step-towards-personalized-medicine\/","og_locale":"en_US","og_type":"article","og_title":"Type 2 diabetes: a new step towards personalized medicine | Precidiab","og_description":"Patients with type 2 diabetes may carry a DNA mutation whose identification would allow more precise management.","og_url":"https:\/\/www.precidiab.org\/en\/news\/type-2-diabetes-a-new-step-towards-personalized-medicine\/","og_site_name":"Precidiab","article_published_time":"2020-10-12T10:33:05+00:00","article_modified_time":"2022-08-18T10:44:09+00:00","og_image":[{"width":660,"height":330,"url":"https:\/\/www.precidiab.org\/wp-content\/uploads\/2020\/10\/Nature-Metabolism-Logo.jpg","type":"image\/jpeg"}],"author":"btourbier","twitter_card":"summary_large_image","twitter_misc":{"Written by":"btourbier","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.precidiab.org\/en\/news\/type-2-diabetes-a-new-step-towards-personalized-medicine\/#article","isPartOf":{"@id":"https:\/\/www.precidiab.org\/en\/news\/type-2-diabetes-a-new-step-towards-personalized-medicine\/"},"author":{"name":"btourbier","@id":"https:\/\/www.precidiab.org\/en\/#\/schema\/person\/d6ca115531c8ad59974f11050ababc79"},"headline":"Type 2 diabetes: a new step towards personalized medicine","datePublished":"2020-10-12T10:33:05+00:00","dateModified":"2022-08-18T10:44:09+00:00","mainEntityOfPage":{"@id":"https:\/\/www.precidiab.org\/en\/news\/type-2-diabetes-a-new-step-towards-personalized-medicine\/"},"wordCount":488,"publisher":{"@id":"https:\/\/www.precidiab.org\/en\/#organization"},"image":{"@id":"https:\/\/www.precidiab.org\/en\/news\/type-2-diabetes-a-new-step-towards-personalized-medicine\/#primaryimage"},"thumbnailUrl":"https:\/\/www.precidiab.org\/wp-content\/uploads\/2020\/10\/Nature-Metabolism-Logo.jpg","articleSection":["Actualit\u00e9s","Communiqu\u00e9s de presse"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.precidiab.org\/en\/news\/type-2-diabetes-a-new-step-towards-personalized-medicine\/","url":"https:\/\/www.precidiab.org\/en\/news\/type-2-diabetes-a-new-step-towards-personalized-medicine\/","name":"Type 2 diabetes: a new step towards personalized medicine | Precidiab","isPartOf":{"@id":"https:\/\/www.precidiab.org\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.precidiab.org\/en\/news\/type-2-diabetes-a-new-step-towards-personalized-medicine\/#primaryimage"},"image":{"@id":"https:\/\/www.precidiab.org\/en\/news\/type-2-diabetes-a-new-step-towards-personalized-medicine\/#primaryimage"},"thumbnailUrl":"https:\/\/www.precidiab.org\/wp-content\/uploads\/2020\/10\/Nature-Metabolism-Logo.jpg","datePublished":"2020-10-12T10:33:05+00:00","dateModified":"2022-08-18T10:44:09+00:00","description":"Patients with type 2 diabetes may carry a DNA mutation whose identification would allow more precise management.","breadcrumb":{"@id":"https:\/\/www.precidiab.org\/en\/news\/type-2-diabetes-a-new-step-towards-personalized-medicine\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.precidiab.org\/en\/news\/type-2-diabetes-a-new-step-towards-personalized-medicine\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.precidiab.org\/en\/news\/type-2-diabetes-a-new-step-towards-personalized-medicine\/#primaryimage","url":"https:\/\/www.precidiab.org\/wp-content\/uploads\/2020\/10\/Nature-Metabolism-Logo.jpg","contentUrl":"https:\/\/www.precidiab.org\/wp-content\/uploads\/2020\/10\/Nature-Metabolism-Logo.jpg","width":660,"height":330},{"@type":"BreadcrumbList","@id":"https:\/\/www.precidiab.org\/en\/news\/type-2-diabetes-a-new-step-towards-personalized-medicine\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.precidiab.org\/en\/"},{"@type":"ListItem","position":2,"name":"Type 2 diabetes: a new step towards personalized medicine"}]},{"@type":"WebSite","@id":"https:\/\/www.precidiab.org\/en\/#website","url":"https:\/\/www.precidiab.org\/en\/","name":"Precidiab","description":"Centre National de M\u00e9decine de Pr\u00e9cision des Diab\u00e8tes","publisher":{"@id":"https:\/\/www.precidiab.org\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.precidiab.org\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.precidiab.org\/en\/#organization","name":"Precidiab","url":"https:\/\/www.precidiab.org\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.precidiab.org\/en\/#\/schema\/logo\/image\/","url":"https:\/\/www.precidiab.org\/wp-content\/uploads\/2022\/07\/Logo-PRECIDIAB.png","contentUrl":"https:\/\/www.precidiab.org\/wp-content\/uploads\/2022\/07\/Logo-PRECIDIAB.png","width":600,"height":257,"caption":"Precidiab"},"image":{"@id":"https:\/\/www.precidiab.org\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/www.precidiab.org\/en\/#\/schema\/person\/d6ca115531c8ad59974f11050ababc79","name":"btourbier","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/ede517e541c034054feafdd8a7a03fd3293fc75d1b87991c98533026c9921d33?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/ede517e541c034054feafdd8a7a03fd3293fc75d1b87991c98533026c9921d33?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/ede517e541c034054feafdd8a7a03fd3293fc75d1b87991c98533026c9921d33?s=96&d=mm&r=g","caption":"btourbier"},"sameAs":["https:\/\/precidiab.tw-es1.ovh"],"url":"https:\/\/www.precidiab.org\/en\/author\/btourbier\/"}]}},"_links":{"self":[{"href":"https:\/\/www.precidiab.org\/en\/wp-json\/wp\/v2\/posts\/9014","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.precidiab.org\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.precidiab.org\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.precidiab.org\/en\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.precidiab.org\/en\/wp-json\/wp\/v2\/comments?post=9014"}],"version-history":[{"count":0,"href":"https:\/\/www.precidiab.org\/en\/wp-json\/wp\/v2\/posts\/9014\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.precidiab.org\/en\/wp-json\/wp\/v2\/media\/3078"}],"wp:attachment":[{"href":"https:\/\/www.precidiab.org\/en\/wp-json\/wp\/v2\/media?parent=9014"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.precidiab.org\/en\/wp-json\/wp\/v2\/categories?post=9014"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.precidiab.org\/en\/wp-json\/wp\/v2\/tags?post=9014"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}